Targeted therapies in RAS-RAF-MAPK pathway
Targeted therapies in RAS-RAF-MAPK pathway. Approved treatments and treatments under investigation in RAS-RAF-MEK-ERK and PI3K-AKT-mTOR pathways. Treatments in ongoing clinical trials are marked with an asterisk (not approved by the FDA). Abbreviations: T-DM1, trastuzumab emtansine; T-DXd, trastuzumab deruxtecan
Publication
Current and Emerging Treatment Paradigms in Colorectal Cancer: Integrating Hallmarks of Cancer (2024) Clara Salva de Torres, et al. Int J Mol Sci. 2024 Jul;25(13). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | ALK1 | ALK1 | ncbigene_synonym | ACVRL1 | 94 |
| Homo sapiens | Primates | ALK1 | ALK1 | ncbigene_synonym | ALK | 238 |
| Homo sapiens | Primates | ALK1 | ALK1 | ncbigene_synonym | SLPI | 6590 |
| Homo sapiens | Primates | EGFR | EGFR | ncbigene_symbol | EGFR | 1956 |
| Homo sapiens | Primates | HER2-4 | HER3 | ncbigene_synonym | ERBB3 | 2065 |
| Homo sapiens | Primates | HER2-4 | HER4 | ncbigene_synonym | ERBB4 | 2066 |
| Homo sapiens | Primates | HER2-4 | HER2 | ncbigene_synonym | ERBB2 | 2064 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR1 | 2260 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR2 | 2263 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR3 | 2261 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFR4 | 2264 |
| Homo sapiens | Primates | FGFR | FGFR | famplex_relations | FGFRL1 | 53834 |
| Homo sapiens | Primates | RET | RET | ncbigene_symbol | RET | 5979 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_symbol | KRAS | 3845 |
| Homo sapiens | Primates | KRAS | KRAS | ncbigene_synonym | NRAS | 4893 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAF | RAF | ncbigene_synonym | ZHX2 | 22882 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | ARAF | 369 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | BRAF | 673 |
| Homo sapiens | Primates | RAF | RAF | famplex_relations | RAF1 | 5894 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | PTEN | PTEN | ncbigene_symbol | PTEN | 5728 |
| Homo sapiens | Primates | MEK | MEK | ncbigene_synonym | MAP2K7 | 5609 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK | MEK | famplex_relations | MAP2K2 | 5605 |
| Homo sapiens | Primates | ERK/MAPK | ERK | ncbigene_synonym | EPHB2 | 2048 |
| Homo sapiens | Primates | ERK/MAPK | ERK | ncbigene_synonym | MAPK1 | 5594 |
| Homo sapiens | Primates | ERK/MAPK | ERK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | ERK/MAPK | MAPK | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | ERK/MAPK | MAPK | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | ERK/MAPK | MAPK | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | ERK/MAPK | MAPK | famplex_relations | MAPK14 | 1432 |
| Homo sapiens | Primates | ERK/MAPK | MAPK | famplex_relations | MAPK8 | 5599 |
| Homo sapiens | Primates | ERK/MAPK | MAPK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | ERK/MAPK | MAPK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | mTOR | MTOR | ncbigene_symbol | MTOR | 2475 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| ROS | ROS | chebi:26523 | ||
| MET | Met | methionine | chebi:16811 | |
| RAS | RAS | (1R)-N-(prop-2-yn-1-yl)indan-1-amine | chebi:63620 | |
| MEK | MEK | butan-2-one | chebi:28398 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | cancer | cancer | DOID:162 |